pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
AVT-001
Type 1 Diabetes (Juvenile Diabetes)
Avotres Inc
0 catalysts
Phase 2
AXER-204
Chronic Spinal Cord Injury
ReNetX Bio
0 catalysts
Phase 2
AZD-0120
Refractory Multiple Myeloma
Gracell Biotechnologies Inc
0 catalysts
Phase 2
AZD-0292
Bronchiectasis
ASTRAZENECA PLC
← prev
page 6 of 50
next →
131
Pain89
Neurology1
$AZN
0 catalysts
Phase 2
AZD-5148
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
AZD-5863
Adenocarcinoma Of The Gastroesophageal Junction
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
AZD-7760
Staphylococcus aureus Infections
$AZNASTRAZENECA PLC
0 catalysts
Phase 2
AbGn-268
Ulcerative Colitis
AltruBio Inc
0 catalysts
Phase 2
Activated T Lymphocytes
Hepatocellular Carcinoma
Lukas Biomedical Inc
0 catalysts
Phase 2
AdAPT-001
Chondrosarcoma
EpicentRx Inc
0 catalysts
Phase 2
Adipose Tissue Derived Mesenchymal Stem Cells
Coronavirus Disease 2019 (COVID-19)
CellTex Therapeutics Corp
0 catalysts
Phase 2
AlloStemspine
olastrocel [INN]
Chronic Low Back Pain (CLBP)
$CELZCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
0 catalysts
Phase 2
AstroRx
Amyotrophic Lateral Sclerosis
$NCELNewcelX Ltd.
0 catalysts
Phase 2
AstroStem
RNL-Astrostem
Spinal Cord Injury
Nature Cell Co., Ltd.
0 catalysts
Phase 2
AstroStem-V
Coronavirus Disease 2019 (COVID-19) Pneumonia
Nature Cell Co., Ltd.
0 catalysts
Phase 2
Autologous Adipose-derived Stem Cells
Osteoarthritis
CellTex Therapeutics Corp
0 catalysts
Phase 2
Autologous Induced Pluripotent Stem Cell (iPSC)-Derived Dopamine Neurons
Parkinson's Disease
Oryon Cell Therapies Inc
0 catalysts
Phase 2
BAT-8006
Epithelial Ovarian Cancer
Bio-Thera Solutions Ltd
0 catalysts
Phase 2
BAY-3401016
Alport Syndrome
Bayer AG
0 catalysts
Phase 2
BB-1701
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Bliss Biopharmaceutical (Hangzhou) Co Ltd
0 catalysts
Phase 2
BB-301
Pabparna
Oculopharyngeal Muscular Dystrophy
$BNTCBenitec Biopharma Inc.
0 catalysts
Phase 2
BBP-812
Canavan Disease
Aspa Therapeutics Inc
0 catalysts
Phase 2
BBT-207
Non-Small Cell Lung Cancer
Parataxis Korea Inc
0 catalysts
Phase 2
BBT-401
Ulcerative Colitis
Parataxis Korea Inc
0 catalysts
Phase 2
BBT-877
Idiopathic Pulmonary Fibrosis
Parataxis Korea Inc
0 catalysts
Phase 2
BCX-17725
Netherton Syndrome (Bamboo Hair)
$BCRXBIOCRYST PHARMACEUTICALS INC
0 catalysts
Phase 2
BDTX-4933
Metastatic Colorectal Cancer
Les Laboratoires Servier SAS
0 catalysts
Phase 2
BE-101
Hemophilia B (Factor IX Deficiency)
Be Biopharma Inc
0 catalysts
Phase 2
BEAM-201
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$BEAMBeam Therapeutics Inc.
0 catalysts
Phase 2
BEAM-301
Glycogen Storage Disease 1A
$BEAMBeam Therapeutics Inc.
0 catalysts